These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21219875)

  • 1. Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cells.
    Li X; Pan YZ; Seigel GM; Hu ZH; Huang M; Yu AM
    Biochem Pharmacol; 2011 Mar; 81(6):783-92. PubMed ID: 21219875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2.
    To KK; Robey RW; Knutsen T; Zhan Z; Ried T; Bates SE
    Mol Cancer Ther; 2009 Oct; 8(10):2959-68. PubMed ID: 19825807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells.
    Pan YZ; Morris ME; Yu AM
    Mol Pharmacol; 2009 Jun; 75(6):1374-9. PubMed ID: 19270061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C421A (Q141K) polymorphism enhances the 3'-untranslated region (3'-UTR)-dependent regulation of ATP-binding cassette transporter ABCG2.
    Ripperger A; Benndorf RA
    Biochem Pharmacol; 2016 Mar; 104():139-47. PubMed ID: 26903388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations.
    Wang F; Xue X; Wei J; An Y; Yao J; Cai H; Wu J; Dai C; Qian Z; Xu Z; Miao Y
    Br J Cancer; 2010 Aug; 103(4):567-74. PubMed ID: 20628378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2).
    Ma MT; He M; Wang Y; Jiao XY; Zhao L; Bai XF; Yu ZJ; Wu HZ; Sun ML; Song ZG; Wei MJ
    Cancer Lett; 2013 Oct; 339(1):107-15. PubMed ID: 23879965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
    Jiao X; Zhao L; Ma M; Bai X; He M; Yan Y; Wang Y; Chen Q; Zhao X; Zhou M; Cui Z; Zheng Z; Wang E; Wei M
    Breast Cancer Res Treat; 2013 Jun; 139(3):717-30. PubMed ID: 23780685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-302a/b/c/d cooperatively inhibit BCRP expression to increase drug sensitivity in breast cancer cells.
    Wang Y; Zhao L; Xiao Q; Jiang L; He M; Bai X; Ma M; Jiao X; Wei M
    Gynecol Oncol; 2016 Jun; 141(3):592-601. PubMed ID: 26644266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation and expression of the ATP-binding cassette transporter ABCG2 in human embryonic stem cells.
    Padmanabhan R; Chen KG; Gillet JP; Handley M; Mallon BS; Hamilton RS; Park K; Varma S; Mehaffey MG; Robey PG; McKay RD; Gottesman MM
    Stem Cells; 2012 Oct; 30(10):2175-87. PubMed ID: 22887864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2.
    Shi L; Wang Z; Sun G; Wan Y; Guo J; Fu X
    Neuromolecular Med; 2014 Jun; 16(2):517-28. PubMed ID: 24777293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer.
    To KK; Leung WW; Ng SS
    Exp Cell Res; 2015 Nov; 338(2):222-31. PubMed ID: 26386386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of ABCG2 expression at the 3' untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line.
    To KK; Zhan Z; Litman T; Bates SE
    Mol Cell Biol; 2008 Sep; 28(17):5147-61. PubMed ID: 18573883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma.
    Reustle A; Fisel P; Renner O; Büttner F; Winter S; Rausch S; Kruck S; Nies AT; Hennenlotter J; Scharpf M; Fend F; Stenzl A; Bedke J; Schwab M; Schaeffeler E
    Int J Cancer; 2018 Dec; 143(12):3181-3193. PubMed ID: 30070687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated miR-132 in Lgr5
    Zhang L; Guo X; Zhang D; Fan Y; Qin L; Dong S; Zhang L
    Mol Carcinog; 2017 Sep; 56(9):2022-2034. PubMed ID: 28383763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phorbol ester TPA modulates chemoresistance in the drug sensitive breast cancer cell line MCF-7 by inducing expression of drug efflux transporter ABCG2.
    Kalalinia F; Elahian F; Hassani M; Kasaeeian J; Behravan J
    Asian Pac J Cancer Prev; 2012; 13(6):2979-84. PubMed ID: 22938493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer.
    Xu XT; Xu Q; Tong JL; Zhu MM; Nie F; Chen X; Xiao SD; Ran ZH
    Br J Cancer; 2012 Mar; 106(7):1320-30. PubMed ID: 22453125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small nucleolar RNA-derived microRNA hsa-miR-1291 modulates cellular drug disposition through direct targeting of ABC transporter ABCC1.
    Pan YZ; Zhou A; Hu Z; Yu AM
    Drug Metab Dispos; 2013 Oct; 41(10):1744-51. PubMed ID: 23686318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the ATP-binding cassette membrane transporter, ABCG2, in human and rodent brain microvessel endothelial and glial cell culture systems.
    Lee G; Babakhanian K; Ramaswamy M; Prat A; Wosik K; Bendayan R
    Pharm Res; 2007 Jul; 24(7):1262-74. PubMed ID: 17380269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydrotestosterone Induces Chemo-Resistance of Triple-Negative Breast MDA-MB-231 Cancer Cells Towards Doxorubicin Independent of ABCG2 and miR-328-3p.
    Al-Momany B; Hammad H; Ahram M
    Curr Mol Pharmacol; 2021; 14(5):860-870. PubMed ID: 34061013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2.
    Imai Y; Ishikawa E; Asada S; Sugimoto Y
    Cancer Res; 2005 Jan; 65(2):596-604. PubMed ID: 15695404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.